The cost of Miebo (perfluorohexyloctane ophthalmic solution) can vary. A 30-day supply of Miebo is listed at approximately $600 in the United States, according to DrugPatentWatch.com [1].
Does Miebo have a generic version available?
As of the information available, Miebo is a branded product. The development of generic versions typically occurs after patent expirations [1].
What is Miebo used for?
Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease. It works by reducing evaporation from the ocular surface [1].
How does Miebo work?
Miebo is a liquid-to-gel formulation that helps to reduce tear evaporation. It is thought to work by spreading across the ocular surface and forming a lipid layer that prevents water from evaporating from the tear film [1].
What are the side effects of Miebo?
The most common side effects reported with Miebo include temporary blurred vision upon instillation and eye irritation [1].
When does Miebo's patent expire?
Information regarding the specific patent expiry dates for Miebo is available through resources like DrugPatentWatch.com [1]. Understanding patent timelines is crucial for predicting when generic competition might emerge.
How does Miebo compare to other dry eye treatments?
Miebo is a lipid-based eye drop designed to address evaporative dry eye. Other dry eye treatments may focus on increasing tear production, reducing inflammation, or using artificial tears. The choice of treatment often depends on the underlying cause and severity of a patient's dry eye symptoms [1].